$BLUE News U.S. stocks inch up; Iraq concerns
Post# of 72711
Posted On: 10/12/2014 12:51:44 PM
$BLUE News
U.S. stocks inch up; Iraq concerns weigh 4:37 p.m. June 16, 2014 - Anora Mahmudova
Stock futures drop as Iraq violence ramps up 9:08 a.m. June 16, 2014 - Barbara Kollmeyer
Bluebird Bio jumps 64% on early gene therapy data 7:37 a.m. June 16, 2014 - Ben Eisen
Bluebird Bio jumps 53% on gene therapy data 7:28 a.m. June 16, 2014 - Ben Eisen
InsiderInsights.com Daily Round Up 10/7/14: AGCO Corp., Air T Inc., Eli Lilly, Entegris Inc. 9:32 a.m. Oct. 8, 2014 - Seeking Alpha
Costly Cancer Treatments Face Hurdles 4:25 p.m. Oct. 6, 2014 - The Wall Street Journal Interactive Edition
Insider Trading Alert - BLUE, NVAX And SNCR Traded By Insiders 10:15 a.m. Oct. 6, 2014 - TheStreet.com
InsiderInsights.com Daily Round Up 10/2/14: FGP, INFI, AGCO, OPK 10:14 a.m. Oct. 3, 2014 - Seeking Alpha
Acceleron Hit Over Competitive Concerns, But Investors Overlook Rest of Pipeline 9:21 a.m. Oct. 2, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – PTCT BLUE ACT HCA 1:45 p.m. Sept. 19, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – ACHN BLUE LCI SLXP 7:30 a.m. Sept. 16, 2014 - InvestorPlace.com
InsiderInsights.com Daily Round Up 9/12/14: Martin Midstream, Ladenburg Thalmann, Republic Services, Select Medical 6:42 a.m. Sept. 14, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – VRTX HCA BLUE CYH 8:30 a.m. Sept. 5, 2014 - InvestorPlace.com
Insider Trading Alert - BLUE, BHI And HCP Traded By Insiders 11:00 a.m. Sept. 4, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – LCI HMSY CBPO MNKD 8:45 a.m. Aug. 18, 2014 - InvestorPlace.com
10-Q: BLUEBIRD BIO, INC. 4:29 p.m. Aug. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Coffee Prices Soar; A Look At California's Relentless Drought: Has Cattle Topped Out? 3:44 p.m. Aug. 1, 2014 - Seeking Alpha
bluebird bio, Inc. (BLUE) in Focus: Stock Surges 10.24% - Tale of the Tape 8:44 a.m. July 21, 2014 - Zacks.com
Buying Bluebird's Blockbuster Potential at a Discount. 10:33 a.m. July 17, 2014 - TheStreet.com
Some Elegant Biotech Platforms I Read About While Looking For The Next Regeneron 9:42 a.m. July 16, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up: 7/14/14 12:22 p.m. July 15, 2014 - Seeking Alpha
Grading Sobek's Mid-Year Biotech Stock Predictions 10:14 a.m. July 9, 2014 - TheStreet.com
bluebird buys Seattle-based biotech 5:17 p.m. June 30, 2014 - Seeking Alpha
Biotech Stock Mailbag: Zafgen, Bluebird, MannKind 8:03 a.m. June 20, 2014 - TheStreet.com
bluebird bio to Present at Morgan Stanley Global Health Care Conference 5:30 p.m. Sept. 2, 2014 - BusinessWire - BZX
Critical Alerts For bluebird bio Inc., United Therapeutics Corporation, Mattel Inc, Ulta Salon Cosmetics & Fragrance Inc. and Applied Materials Inc. Released By InvestorsObserver 9:31 a.m. Sept. 2, 2014 - PR Newswire - PRF
bluebird bio Reports Fiscal Second Quarter 2014 Financial Results 5:01 p.m. Aug. 12, 2014 - BusinessWire - BZX
bluebird bio to Present at Two Upcoming Health Care Conferences 4:07 p.m. Aug. 5, 2014 - BusinessWire - BZX
Acquisition Agreements, Rejected Acquisition Tender Offers, Appointment, and Technical Updates - Research Reports on Pfizer, Gentiva, bluebird bio, Agios and AcelRx 8:30 a.m. July 23, 2014 - PR Newswire - PRF
bluebird bio Appoints Mark Vachon to its Board of Directors 4:05 p.m. July 16, 2014 - BusinessWire - BZX
bluebird bio Announces Pricing of Public Offering of Common Stock 6:58 p.m. July 8, 2014 - BusinessWire - BZX
bluebird bio Announces Proposed Public Offering of Common Stock 4:03 p.m. July 7, 2014 - BusinessWire - BZX
Positive Study Results, Patent Grants, Acquisitions, Patient Enrollment, and Earnings Schedule - Analyst Notes on Synageva, OPKO, bluebird bio, BioDelivery Sciences and Haemonetics 5:10 a.m. July 3, 2014 - PR Newswire - PRF
bluebird bio Acquires Precision Genome Engineering, a Privately Held Gene-Editing Company 4:05 p.m. June 30, 2014 - BusinessWire - BZX
Clinical Studies, Review Extensions, Appointments, and Conference Schedules - Analyst Notes on Karyopharm, Orexigen, INSYS, bluebird bio and AMAG Pharmaceuticals 6:30 a.m. June 18, 2014 - PR Newswire - PRF
Critical Alerts For Coca-Cola, bluebird bio, International Business Machines, SPDR Gold Trust, and American Express Released By InvestorsObserver 9:31 a.m. June 17, 2014 - PR Newswire - PRF
bluebird bio Reports Rapid Transfusion Independence in Beta-Thalassemia Major Patients Treated with its LentiGlobin Product Candidate 10:30 a.m. June 14, 2014 - BusinessWire - BZX
bluebird bio to Host a Conference Call to Discuss Initial Results from the HGB-205 Study in Beta-Thalassemia Major Subjects 4:05 p.m. June 9, 2014 - BusinessWire - BZX
bluebird bio to present initial clinical data from its HGB-205 Study in beta-thalassemia major patients at the 19th European Hematology Association Congress 5:31 p.m. May 21, 2014 - BusinessWire - BZX
Business Highlights, Financial Results, and Leadership Appointments - Analyst Notes on PDL BioPharma, bluebird, Osiris, Agios and Ophthotech 7:00 a.m. May 19, 2014 - PR Newswire - PRF
bluebird bio Reports Fiscal First Quarter 2014 Financial Results 4:01 p.m. May 13, 2014 - BusinessWire - BZX
bluebird bio Announces First Patient Transplanted in Phase 1/2 Northstar Study for the Treatment of Beta-Thalassemia 7:01 a.m. March 27, 2014 - BusinessWire - BZX
Healthcare Companies Report Clinical Study Results, Financial Results and Stock Summaries - Analyst Notes on Endocyte, Ophthotech, AcelRx Pharmaceuticals, bluebird bio, and Cantel Medical 8:00 a.m. March 26, 2014 - PR Newswire - PRF
bluebird bio Reports Fiscal Year End 2013 Financial Results 5:31 p.m. March 5, 2014 - BusinessWire - BZX
U.S. stocks inch up; Iraq concerns weigh 4:37 p.m. June 16, 2014 - Anora Mahmudova
Stock futures drop as Iraq violence ramps up 9:08 a.m. June 16, 2014 - Barbara Kollmeyer
Bluebird Bio jumps 64% on early gene therapy data 7:37 a.m. June 16, 2014 - Ben Eisen
Bluebird Bio jumps 53% on gene therapy data 7:28 a.m. June 16, 2014 - Ben Eisen
InsiderInsights.com Daily Round Up 10/7/14: AGCO Corp., Air T Inc., Eli Lilly, Entegris Inc. 9:32 a.m. Oct. 8, 2014 - Seeking Alpha
Costly Cancer Treatments Face Hurdles 4:25 p.m. Oct. 6, 2014 - The Wall Street Journal Interactive Edition
Insider Trading Alert - BLUE, NVAX And SNCR Traded By Insiders 10:15 a.m. Oct. 6, 2014 - TheStreet.com
InsiderInsights.com Daily Round Up 10/2/14: FGP, INFI, AGCO, OPK 10:14 a.m. Oct. 3, 2014 - Seeking Alpha
Acceleron Hit Over Competitive Concerns, But Investors Overlook Rest of Pipeline 9:21 a.m. Oct. 2, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – PTCT BLUE ACT HCA 1:45 p.m. Sept. 19, 2014 - InvestorPlace.com
Hottest Healthcare Stocks Now – ACHN BLUE LCI SLXP 7:30 a.m. Sept. 16, 2014 - InvestorPlace.com
InsiderInsights.com Daily Round Up 9/12/14: Martin Midstream, Ladenburg Thalmann, Republic Services, Select Medical 6:42 a.m. Sept. 14, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – VRTX HCA BLUE CYH 8:30 a.m. Sept. 5, 2014 - InvestorPlace.com
Insider Trading Alert - BLUE, BHI And HCP Traded By Insiders 11:00 a.m. Sept. 4, 2014 - TheStreet.com
Hottest Healthcare Stocks Now – LCI HMSY CBPO MNKD 8:45 a.m. Aug. 18, 2014 - InvestorPlace.com
10-Q: BLUEBIRD BIO, INC. 4:29 p.m. Aug. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Coffee Prices Soar; A Look At California's Relentless Drought: Has Cattle Topped Out? 3:44 p.m. Aug. 1, 2014 - Seeking Alpha
bluebird bio, Inc. (BLUE) in Focus: Stock Surges 10.24% - Tale of the Tape 8:44 a.m. July 21, 2014 - Zacks.com
Buying Bluebird's Blockbuster Potential at a Discount. 10:33 a.m. July 17, 2014 - TheStreet.com
Some Elegant Biotech Platforms I Read About While Looking For The Next Regeneron 9:42 a.m. July 16, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up: 7/14/14 12:22 p.m. July 15, 2014 - Seeking Alpha
Grading Sobek's Mid-Year Biotech Stock Predictions 10:14 a.m. July 9, 2014 - TheStreet.com
bluebird buys Seattle-based biotech 5:17 p.m. June 30, 2014 - Seeking Alpha
Biotech Stock Mailbag: Zafgen, Bluebird, MannKind 8:03 a.m. June 20, 2014 - TheStreet.com
bluebird bio to Present at Morgan Stanley Global Health Care Conference 5:30 p.m. Sept. 2, 2014 - BusinessWire - BZX
Critical Alerts For bluebird bio Inc., United Therapeutics Corporation, Mattel Inc, Ulta Salon Cosmetics & Fragrance Inc. and Applied Materials Inc. Released By InvestorsObserver 9:31 a.m. Sept. 2, 2014 - PR Newswire - PRF
bluebird bio Reports Fiscal Second Quarter 2014 Financial Results 5:01 p.m. Aug. 12, 2014 - BusinessWire - BZX
bluebird bio to Present at Two Upcoming Health Care Conferences 4:07 p.m. Aug. 5, 2014 - BusinessWire - BZX
Acquisition Agreements, Rejected Acquisition Tender Offers, Appointment, and Technical Updates - Research Reports on Pfizer, Gentiva, bluebird bio, Agios and AcelRx 8:30 a.m. July 23, 2014 - PR Newswire - PRF
bluebird bio Appoints Mark Vachon to its Board of Directors 4:05 p.m. July 16, 2014 - BusinessWire - BZX
bluebird bio Announces Pricing of Public Offering of Common Stock 6:58 p.m. July 8, 2014 - BusinessWire - BZX
bluebird bio Announces Proposed Public Offering of Common Stock 4:03 p.m. July 7, 2014 - BusinessWire - BZX
Positive Study Results, Patent Grants, Acquisitions, Patient Enrollment, and Earnings Schedule - Analyst Notes on Synageva, OPKO, bluebird bio, BioDelivery Sciences and Haemonetics 5:10 a.m. July 3, 2014 - PR Newswire - PRF
bluebird bio Acquires Precision Genome Engineering, a Privately Held Gene-Editing Company 4:05 p.m. June 30, 2014 - BusinessWire - BZX
Clinical Studies, Review Extensions, Appointments, and Conference Schedules - Analyst Notes on Karyopharm, Orexigen, INSYS, bluebird bio and AMAG Pharmaceuticals 6:30 a.m. June 18, 2014 - PR Newswire - PRF
Critical Alerts For Coca-Cola, bluebird bio, International Business Machines, SPDR Gold Trust, and American Express Released By InvestorsObserver 9:31 a.m. June 17, 2014 - PR Newswire - PRF
bluebird bio Reports Rapid Transfusion Independence in Beta-Thalassemia Major Patients Treated with its LentiGlobin Product Candidate 10:30 a.m. June 14, 2014 - BusinessWire - BZX
bluebird bio to Host a Conference Call to Discuss Initial Results from the HGB-205 Study in Beta-Thalassemia Major Subjects 4:05 p.m. June 9, 2014 - BusinessWire - BZX
bluebird bio to present initial clinical data from its HGB-205 Study in beta-thalassemia major patients at the 19th European Hematology Association Congress 5:31 p.m. May 21, 2014 - BusinessWire - BZX
Business Highlights, Financial Results, and Leadership Appointments - Analyst Notes on PDL BioPharma, bluebird, Osiris, Agios and Ophthotech 7:00 a.m. May 19, 2014 - PR Newswire - PRF
bluebird bio Reports Fiscal First Quarter 2014 Financial Results 4:01 p.m. May 13, 2014 - BusinessWire - BZX
bluebird bio Announces First Patient Transplanted in Phase 1/2 Northstar Study for the Treatment of Beta-Thalassemia 7:01 a.m. March 27, 2014 - BusinessWire - BZX
Healthcare Companies Report Clinical Study Results, Financial Results and Stock Summaries - Analyst Notes on Endocyte, Ophthotech, AcelRx Pharmaceuticals, bluebird bio, and Cantel Medical 8:00 a.m. March 26, 2014 - PR Newswire - PRF
bluebird bio Reports Fiscal Year End 2013 Financial Results 5:31 p.m. March 5, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼